Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
24 Leser
Artikel bewerten:
(0)

Venipuncture Needle and Syringes Market Worth 1,044.6 Million USD by 2021

PUNE, India, March 15, 2017 /PRNewswire/ --

According to a new market research report "Venipuncture Procedure Analysis by Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021" published by MarketsandMarkets, the market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period.

(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 43 market data Tables and 69 Figures spread through 75 Pages and in-depth TOC on "Venipuncture Needle and Syringes Market"

http://www.marketsandmarkets.com/Market-Reports/venipuncture-procedure-analysis-105976374.html

Early buyers will receive 10% customization on this report.

The Venipuncture Procedure Analysis Report studies the total volume of venipuncture procedure and successful number of venipuncture procedures/interventions in the U.S., Canada, the U.K. (including Ireland), Germany, France, Italy, Spain, Benelux (Belgium, the Netherlands, and Luxembourg), Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden), Australia, Switzerland, and Austria. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%. The modest growth is due to the technological advancement in venipuncture procedure resulting in increasing successful venipuncture procedures. The increase in successful venipuncture procedure will eventually decrease the number of unsuccessful venipuncture attempts and total number of venipuncture procedure.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=105976374

The surgical puncture of a vein, especially for the withdrawal of a blood sample for diagnostic purpose is called venipuncture. Venipuncture can be done through venous access. The fingerstick method of blood sample collection has not been considered while studying the venipuncture procedures, as, by definition, it is not the direct puncturing of a vein.

This study covers the venipuncture procedure analysis based on the success rate (total venipuncture and successful venipuncture), vein type (cephalic vein, median cubital vein, basilic vein, and other veins), end user [hospitals (public and private), diagnostic laboratories, physician office laboratories, and other end users], and geographic countries (the U.S., the U.K., Germany, France, Canada, Spain, Italy, Benelux, Nordic Countries, Australia, Switzerland, and Austria).

Based on vein type, the U.S. venipuncture procedures are classified into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. The procedures in each vein type are further divided into total venipuncture procedures and successful venipuncture procedures. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures.

Speak to Our Expert @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=105976374

Based on end user, the U.K. venipuncture procedures are classified into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.

The Germany vein type segment is divided into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures. Based on end user, the Germany venipuncture procedures are segmented into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.

Browse Related Reports:

Blood Screening Market by Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecasts to 2021

http://www.marketsandmarkets.com/Market-Reports/blood-screening-market-267747042.html

Blood Collection Market by Product (Syringes, Needles, EDTA, Heparin, Serum, Tubes, Blood Lancets, Blood Bags, Vials), Application (Diagnostic, Treatment, Infectious Diseases, Non Infectious Diseases) & End User (Blood Banks, Hospitals) - Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/blood-collection-market-39733117.html

About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices

Connect with us on LinkedIn @http://www.linkedin.com/company/marketsandmarkets


© 2017 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.